Is Alcon AG (ALC) a risky stock?
As of July 22, 2026, Clavix grades Alcon AG (ALC) A- for risk, a composite score of 83 out of 100 on an A+ to F scale, which puts ALC in the "low risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 22, 2026. Clavix regrades every trading day.
The five risk dimensions behind ALC's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how ALC scores on each, as of July 22, 2026.
What's moving ALC's risk right now
Company-specific signals Clavix flags behind ALC's current grade, drawn from recent news and filings as of July 22, 2026.
Enables natural orifice extraction of tissue without surgical incision SINGAPORE, July 20, 2026 /PRNewswire/ -- NICE Surgical Solutions Pte Ltd ("NICE Surgical"), a clinical-stage…
India represents a significant long-term revenue growth driver for Alcon as the company positions itself to capture demand in a large underserved emerging market, potentially supp…
DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.
Recent ALC news
The latest headlines Clavix ingested for Alcon AG, newest first. These feed the news-sentiment dimension of ALC's grade.
-
Alcon is significantly increasing investments in India's eye care market, citing rising eye disorders among younger Indians as a key growth driver, with plans to expand innovation and surgeon training programs and evaluate future local manufacturing.
What a A- grade means
On the Clavix A+ to F scale, ALC's composite of 83 falls in the A band (80–100), read as "low risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell ALC or any security. Grades are risk indicators, not predictions of return. Data may be delayed.